CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- 4 Grant or award See Remarks acquired 20,080 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale See Remarks sold 896 shares at $10.38 ($9,300)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale See Remarks sold 1,224 shares at $13.05 ($15,978)
- 4 Open-market sale See Remarks sold 4,588 shares at $13.05 ($59,892)
- 4 Open-market sale CEO sold 11,091 shares at $13.05 ($144,782)
- 4 Open-market sale General Counsel sold 1,175 shares at $13.05 ($15,338)
- 4 Open-market sale See Remarks sold 3,080 shares at $16.63 ($51,205)
- 4 Open-market sale See Remarks sold 917 shares at $16.63 ($15,245)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale See Remarks sold 1,064 shares at $18.50 ($19,688)
- 4 Open-market sale See Remarks sold 3,989 shares at $18.50 ($73,812)
- 4 Open-market sale CEO sold 9,650 shares at $18.50 ($178,564)
- 4 Open-market sale General Counsel sold 1,027 shares at $18.50 ($19,004)
- 4 Open-market sale See Remarks sold 812 shares at $23.02 ($18,688)
Page 6 of 21 · 406 filings